190 related articles for article (PubMed ID: 12200129)
1. Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties.
Yamagishi S; Inagaki Y; Amano S; Okamoto T; Takeuchi M; Makita Z
Biochem Biophys Res Commun; 2002 Aug; 296(4):877-82. PubMed ID: 12200129
[TBL] [Abstract][Full Text] [Related]
2. Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes.
Amano S; Yamagishi S; Inagaki Y; Nakamura K; Takeuchi M; Inoue H; Imaizumi T
Microvasc Res; 2005 Jan; 69(1-2):45-55. PubMed ID: 15797260
[TBL] [Abstract][Full Text] [Related]
3. Pigment epithelium-derived factor inhibits advanced glycation end-products-induced cytotoxicity in retinal pericytes.
Sheikpranbabu S; Haribalaganesh R; Gurunathan S
Diabetes Metab; 2011 Dec; 37(6):505-11. PubMed ID: 21636306
[TBL] [Abstract][Full Text] [Related]
4. Pigment epithelium-derived factor (PEDF) promotes growth of pericytes through autocrine production of platelet-derived growth factor-B.
Yamagishi S; Nakamura K; Takenaka K; Matsui T; Jinnouchi Y; Imaizumi T
Microvasc Res; 2005 May; 69(3):128-34. PubMed ID: 15896354
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of PEDF-mediated protection against reactive oxygen species damage in diabetic retinopathy and neuropathy.
Elahy M; Baindur-Hudson S; Cruzat VF; Newsholme P; Dass CR
J Endocrinol; 2014 Sep; 222(3):R129-39. PubMed ID: 24928938
[TBL] [Abstract][Full Text] [Related]
6. Pigment-epithelium-derived factor down regulates hyperglycemia-induced apoptosis via PI3K/Akt activation in goat retinal pericytes.
Haribalaganesh R; Sheikpranbabu S; Elayappan B; Venkataraman D; Gurunathan S
Angiogenesis; 2009; 12(4):381-9. PubMed ID: 19904621
[TBL] [Abstract][Full Text] [Related]
7. Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression.
Yamagishi S; Nakamura K; Matsui T; Inagaki Y; Takenaka K; Jinnouchi Y; Yoshida Y; Matsuura T; Narama I; Motomiya Y; Takeuchi M; Inoue H; Yoshimura A; Bucala R; Imaizumi T
J Biol Chem; 2006 Jul; 281(29):20213-20. PubMed ID: 16707486
[TBL] [Abstract][Full Text] [Related]
8. Pigment epithelium-derived factor is a pericyte mitogen secreted by microvascular endothelial cells: possible participation of angiotensin II-elicited PEDF downregulation in diabetic retinopathy.
Yamagishi S; Matsui T; Nakamura K; Inoue H
Int J Tissue React; 2005; 27(4):197-202. PubMed ID: 16440585
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of vascular endothelial growth factor and down-regulation of pigment epithelium-derived factor messenger ribonucleic acid levels in leptin-exposed cultured retinal pericytes.
Yamagishi S; Inagaki Y; Amano S; Okamoto T; Takeuchi M
Int J Tissue React; 2002; 24(4):137-42. PubMed ID: 12779248
[TBL] [Abstract][Full Text] [Related]
10. Sulforaphane inhibits advanced glycation end product-induced pericyte damage by reducing expression of receptor for advanced glycation end products.
Maeda S; Matsui T; Ojima A; Takeuchi M; Yamagishi S
Nutr Res; 2014 Sep; 34(9):807-13. PubMed ID: 25241332
[TBL] [Abstract][Full Text] [Related]
11. Pigment epithelium-derived factor inhibits advanced glycation end-product-induced angiogenesis and stimulates apoptosis in retinal endothelial cells.
Sheikpranbabu S; Haribalaganesh R; Banumathi E; Sirishkumar N; Lee KJ; Gurunathan S
Life Sci; 2009 Nov; 85(21-22):719-31. PubMed ID: 19818798
[TBL] [Abstract][Full Text] [Related]
12. Pigment epithelium-derived factor mitigates inflammation and oxidative stress in retinal pericytes exposed to oxidized low-density lipoprotein.
Zhang SX; Wang JJ; Dashti A; Wilson K; Zou MH; Szweda L; Ma JX; Lyons TJ
J Mol Endocrinol; 2008 Sep; 41(3):135-43. PubMed ID: 18586837
[TBL] [Abstract][Full Text] [Related]
13. Pigment epithelium-derived factor inhibits advanced glycation end product-elicited mesangial cell damage by blocking NF-kappaB activation.
Ide Y; Matsui T; Ishibashi Y; Takeuchi M; Yamagishi S
Microvasc Res; 2010 Sep; 80(2):227-32. PubMed ID: 20381502
[TBL] [Abstract][Full Text] [Related]
14. [Role of the retinal pigment epithelium (RPE) in the pathogenesis and treatment of diabetic macular edema (DME)].
Chmielewska K; Robaszkiewicz J; Kosatka M
Klin Oczna; 2008; 110(7-9):318-20. PubMed ID: 19112870
[TBL] [Abstract][Full Text] [Related]
15. Beraprost sodium, a prostaglandin I2 analogue, protects against advanced gycation end products-induced injury in cultured retinal pericytes.
Yamagishi S; Amano S; Inagaki Y; Okamoto T; Takeuchi M; Makita Z
Mol Med; 2002 Sep; 8(9):546-50. PubMed ID: 12456993
[TBL] [Abstract][Full Text] [Related]
16. Pigment epithelium-derived factor inhibits leptin-induced angiogenesis by suppressing vascular endothelial growth factor gene expression through anti-oxidative properties.
Yamagishi S; Amano S; Inagaki Y; Okamoto T; Takeuchi M; Inoue H
Microvasc Res; 2003 May; 65(3):186-90. PubMed ID: 12711260
[TBL] [Abstract][Full Text] [Related]
17. Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats.
Yamagishi S; Matsui T; Nakamura K; Yoshida T; Takeuchi M; Inoue H; Yoshida Y; Imaizumi T
Ophthalmic Res; 2007; 39(2):92-7. PubMed ID: 17284935
[TBL] [Abstract][Full Text] [Related]
18. Pigment epithelium-derived factor (PEDF) prevents diabetes- or advanced glycation end products (AGE)-elicited retinal leukostasis.
Yamagishi S; Matsui T; Nakamura K; Takeuchi M; Imaizumi T
Microvasc Res; 2006; 72(1-2):86-90. PubMed ID: 16797605
[TBL] [Abstract][Full Text] [Related]
19. Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF.
Yamagishi S; Nakamura K; Ueda S; Kato S; Imaizumi T
Cell Tissue Res; 2005 Jun; 320(3):437-45. PubMed ID: 15846509
[TBL] [Abstract][Full Text] [Related]
20. Protective role of pigment epithelium-derived factor (PEDF) in early phase of experimental diabetic retinopathy.
Yoshida Y; Yamagishi S; Matsui T; Jinnouchi Y; Fukami K; Imaizumi T; Yamakawa R
Diabetes Metab Res Rev; 2009 Oct; 25(7):678-86. PubMed ID: 19685553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
